U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 1059

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:2098588-2115636
GRCh38:
Chr16:2048587-2065635
TSC2Tuberous sclerosis 2Pathogenic
(Sep 27, 2016)
criteria provided, single submitter
2.
GRCh37:
Chr16:2098597-2124416
GRCh38:
Chr16:2048596-2074415
TSC2Tuberous sclerosis 2Pathogenic
(Jul 31, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr16:2098597-2098774
GRCh38:
Chr16:2048596-2048773
TSC2Tuberous sclerosis 2Pathogenic
(Aug 12, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr16:2098611-2138617
GRCh38:
Chr16:2048610-2088616
TSC2Tuberous sclerosis 2Pathogenic
(Nov 30, 2017)
criteria provided, single submitter
5.
GRCh37:
Chr16:2098619
GRCh38:
Chr16:2048618
TSC2M1I, M12Inot providedLikely pathogenic
(Sep 12, 2017)
criteria provided, single submitter
6.
GRCh37:
Chr16:2098625-2098626
GRCh38:
Chr16:2048624-2048625
TSC2T5fs, T16fsnot providedLikely pathogenic
(Jan 7, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr16:2098628
GRCh38:
Chr16:2048627
TSC2T16fs, T5fsTuberous sclerosis 2Pathogenic
(Apr 15, 2019)
criteria provided, single submitter
8.
GRCh37:
Chr16:2098630-2098631
GRCh38:
Chr16:2048629-2048630
TSC2S17fs, S6fsTuberous sclerosis 2Pathogenic
(Feb 1, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr16:2098635-2098636
GRCh38:
Chr16:2048634-2048635
TSC2K18fs, K7fsTuberous sclerosis 2Pathogenic
(Dec 20, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr16:2098635
GRCh38:
Chr16:2048634
TSC2D19fs, D8fsnot providedPathogenic
(Oct 23, 2019)
criteria provided, single submitter
11.
GRCh37:
Chr16:2098638
GRCh38:
Chr16:2048637
TSC2D8fs, D19fsTuberous sclerosis 2Pathogenic
(Jul 9, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr16:2098642
GRCh38:
Chr16:2048641
TSC2S9*, S20*Tuberous sclerosis 2Pathogenic
(Aug 12, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr16:2098645-2131595
GRCh38:
Chr16:2048644-2081594
TSC2Tuberous sclerosis 2Pathogenic
(Jun 30, 2016)
criteria provided, single submitter
14.
GRCh37:
Chr16:2098647
GRCh38:
Chr16:2048646
TSC2not providedPathogenic
(Oct 3, 2014)
criteria provided, single submitter
15.
GRCh37:
Chr16:2098650
GRCh38:
Chr16:2048649
TSC2K12*, K23*Tuberous sclerosis 2Pathogenic
(Jan 1, 1996)
no assertion criteria provided
16.
GRCh37:
Chr16:2098656
GRCh38:
Chr16:2048655
TSC2K14fs, K25fsTuberous sclerosis 2Pathogenic
(Apr 9, 2019)
criteria provided, single submitter
17.
GRCh37:
Chr16:2098658-2098659
GRCh38:
Chr16:2048657-2048658
TSC2K16*, K27*Tuberous sclerosis 2Pathogenic
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:2098659-2098665
GRCh38:
Chr16:2048658-2048664
TSC2K27fs, K16fsTuberous sclerosis 2Pathogenic
(Jul 10, 2020)
criteria provided, single submitter
19.
GRCh37:
Chr16:2098700-2098718
GRCh38:
Chr16:2048699-2048717
TSC2S30fs, S41fsnot providedPathogenic
(Sep 18, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr16:2098708-2098718
GRCh38:
Chr16:2048707-2048717
TSC2E32fs, E43fsTuberous sclerosis 2Pathogenic
(Aug 9, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr16:2098720-2098721
GRCh38:
Chr16:2048719-2048720
TSC2Q35fs, Q46fsTuberous sclerosis 2Pathogenic
(Mar 26, 2019)
criteria provided, single submitter
22.
GRCh37:
Chr16:2098721-2098722
GRCh38:
Chr16:2048720-2048721
TSC2Tuberous sclerosis 2Pathogenic
(Aug 12, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr16:2098725
GRCh38:
Chr16:2048724
TSC2E37*, E48*Tuberous sclerosis 2Likely pathogenic
(Jan 4, 2023)
criteria provided, single submitter
24.
GRCh37:
Chr16:2098727-2098728
GRCh38:
Chr16:2048726-2048727
TSC2I39fs, I50fsnot providedPathogenic
(Sep 15, 2017)
criteria provided, single submitter
25.
GRCh37:
Chr16:2098730-2098731
GRCh38:
Chr16:2048729-2048730
TSC2I39fs, I50fsTuberous sclerosis 2Pathogenic
(Jan 13, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr16:2098731-2098732
GRCh38:
Chr16:2048730-2048731
TSC2A53fs, A42fsTuberous sclerosis 2Pathogenic
(Sep 13, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr16:2098736
GRCh38:
Chr16:2048735
TSC2T41fs, T52fsTuberous sclerosis 2Pathogenic
(Jan 3, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr16:2098746-2098747
GRCh38:
Chr16:2048745-2048746
TSC2I44fs, I55fsnot providedPathogenic
(Jul 16, 2015)
criteria provided, single submitter
29.
GRCh37:
Chr16:2098747-2098748
GRCh38:
Chr16:2048746-2048747
TSC2L45fs, L56fsnot providedPathogenic
(Mar 1, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr16:2098748-2098751
GRCh38:
Chr16:2048747-2048750
TSC2L45fs, L56fsTuberous sclerosis 2, not providedPathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr16:2098750-2098755
GRCh38:
Chr16:2048749-2048754
TSC2not providedPathogenic
(Nov 22, 2016)
criteria provided, single submitter
32.
GRCh37:
Chr16:2098751-2098754
GRCh38:
Chr16:2048750-2048753
TSC2Tuberous sclerosis 2Pathogenic
(Aug 12, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr16:2098751-2098752
GRCh38:
Chr16:2048750-2048751
TSC2not provided, Tuberous sclerosis 2Pathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:2098752
GRCh38:
Chr16:2048751
TSC2R46*, R57*Tuberous sclerosis 2Pathogenic
(Apr 9, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr16:2098756
GRCh38:
Chr16:2048755
TSC2not provided, Tuberous sclerosis 2Pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr16:2098759
GRCh38:
Chr16:2048758
TSC2Tuberous sclerosis 2Pathogenic
(Sep 1, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr16:2098759
GRCh38:
Chr16:2048758
TSC2Lymphangiomyomatosis, Isolated focal cortical dysplasia type II, Tuberous sclerosis 2,
not provided, Tuberous sclerosis 2
Pathogenic/Likely pathogenic
(Feb 28, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr16:2100381-2115656
GRCh38:
Chr16:2050380-2065655
TSC2Tuberous sclerosis 2Pathogenic
(May 25, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr16:2100391-2100497
GRCh38:
Chr16:2050390-2050496
TSC2Tuberous sclerosis 2Pathogenic
(Oct 29, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr16:2100399
GRCh38:
Chr16:2050398
TSC2Tuberous sclerosis 2Pathogenic
(Jun 22, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr16:2100400
GRCh38:
Chr16:2050399
TSC2Tuberous sclerosis 2Pathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr16:2100401
GRCh38:
Chr16:2050400
TSC2E47*, E58*not providedPathogenic
(Feb 20, 2017)
criteria provided, single submitter
43.
GRCh37:
Chr16:2100422-2100423
GRCh38:
Chr16:2050421-2050422
TSC2L5fs, L65fs, L54fsHereditary cancer-predisposing syndromePathogenic
(Sep 3, 2020)
criteria provided, single submitter
44.
GRCh37:
Chr16:2100466
GRCh38:
Chr16:2050465
TSC2T21fs, T70fs, T81fsTuberous sclerosis 2Pathogenic
(Jun 28, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr16:2100482
GRCh38:
Chr16:2050481
TSC2E85*, E74*, E25*Hereditary cancer-predisposing syndromePathogenic
(Jan 26, 2017)
criteria provided, single submitter
46.
GRCh37:
Chr16:2100488
GRCh38:
Chr16:2050487
TSC2Isolated focal cortical dysplasia type II, Lymphangiomyomatosis, Tuberous sclerosis 2,
Tuberous sclerosis 2
Pathogenic/Likely pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr16:2103323-2107460
GRCh38:
Chr16:2053322-2057459
TSC2Tuberous sclerosis 2Pathogenic
(Aug 4, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr16:2103341
GRCh38:
Chr16:2053340
TSC2Tuberous sclerosis 2Pathogenic
(Sep 3, 2013)
criteria provided, single submitter
49.
GRCh37:
Chr16:2103342
GRCh38:
Chr16:2053341
TSC2Tuberous sclerosis 2Likely pathogenic
(Oct 4, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr16:2103343-2103345
GRCh38:
Chr16:2053342-2053344
TSC2H76*, H87*, H27*Hereditary cancer-predisposing syndromePathogenic
(Sep 14, 2020)
criteria provided, single submitter
51.
GRCh37:
Chr16:2103343-2110814
GRCh38:
Chr16:2053342-2060813
TSC2Tuberous sclerosis 2Pathogenic
(Apr 7, 2016)
criteria provided, single submitter
52.
GRCh37:
Chr16:2103362
GRCh38:
Chr16:2053361
TSC2W82*, W33*, W93*Tuberous sclerosis 2Pathogenic
(Apr 12, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr16:2103363
GRCh38:
Chr16:2053362
TSC2W82*, W33*, W93*Tuberous sclerosis 2Pathogenic
(Aug 31, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr16:2103364
GRCh38:
Chr16:2053363
TSC2K83fs, K94fs, K34fsTuberous sclerosis 2Pathogenic
(Jul 6, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr16:2103367-2103419
GRCh38:
Chr16:2053366-2053418
TSC2V96fs, V36fs, V85fsTuberous sclerosis 2Pathogenic
(Aug 27, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr16:2103384-2103385
GRCh38:
Chr16:2053383-2053384
TSC2Tuberous sclerosis 2Pathogenic
(Oct 1, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr16:2103385
GRCh38:
Chr16:2053384
TSC2Q90*, Q41*, Q101*not provided, Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome
Pathogenic
(Jul 17, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr16:2103409-2103410
GRCh38:
Chr16:2053408-2053409
TSC2H110fs, H50fs, H99fsTuberous sclerosis 2Pathogenic
(Feb 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr16:2103428
GRCh38:
Chr16:2053427
TSC2L104P, L115P, L55PTuberous sclerosis 2Likely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr16:2103438-2103439
GRCh38:
Chr16:2053437-2053438
TSC2I59fs, I119fs, I108fsTuberous sclerosis 2Pathogenic
(Aug 31, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr16:2103445
GRCh38:
Chr16:2053444
TSC2Q110*, Q121*, Q61*Hereditary cancer-predisposing syndrome, not providedPathogenic
(Feb 1, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr16:2103446
GRCh38:
Chr16:2053445
TSC2Q110fs, Q61fs, Q121fsnot providedPathogenic
(Jun 4, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr16:2103448-2103463
GRCh38:
Chr16:2053447-2053462
TSC2Tuberous sclerosis 2Likely pathogenic
(Oct 22, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr16:2103454
GRCh38:
Chr16:2053453
TSC2V64L, V113LTuberous sclerosis 2Pathogenic/Likely pathogenic
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr16:2103454
GRCh38:
Chr16:2053453
TSC2Tuberous sclerosis 2Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr16:2103454
GRCh38:
Chr16:2053453
TSC2Tuberous sclerosis 2Pathogenic
(Dec 2, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr16:2103458
GRCh38:
Chr16:2053457
TSC2Tuberous sclerosis 2, not providedPathogenic/Likely pathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr16:2104295
GRCh38:
Chr16:2054294
TSC2Tuberous sclerosis 2Pathogenic
(Mar 18, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr16:2104296
GRCh38:
Chr16:2054295
TSC2Tuberous sclerosis 2, not providedPathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr16:2104296
GRCh38:
Chr16:2054295
TSC2Hereditary cancer-predisposing syndromePathogenic
(May 21, 2018)
criteria provided, single submitter
71.
GRCh37:
Chr16:2104300
GRCh38:
Chr16:2054299
TSC2E114*, E65*, E125*, E77*Tuberous sclerosis 2Pathogenic
(Apr 17, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr16:2104305
GRCh38:
Chr16:2054304
TSC2L67fs, L116fs, L127fs, L79fsTuberous sclerosis 2Pathogenic
(Dec 29, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr16:2104307-2104308
GRCh38:
Chr16:2054306-2054307
TSC2V81fs, V69fs, V129fs, V118fsHereditary cancer-predisposing syndrome, Tuberous sclerosis 2, not provided
Pathogenic
(Nov 28, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr16:2104308
GRCh38:
Chr16:2054307
TSC2V129fs, V81fs, V118fs, V69fsTuberous sclerosis 2Pathogenic
(Oct 7, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr16:2104317-2104318
GRCh38:
Chr16:2054316-2054317
TSC2Tuberous sclerosis 2Pathogenic
(Sep 19, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr16:2104318
GRCh38:
Chr16:2054317
TSC2R120*, R131*, R71*, R83*Tuberous sclerosis 2, not providedPathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr16:2104318-2104319
GRCh38:
Chr16:2054317-2054318
TSC2R131fs, R120fs, R71fs, R83fsHereditary cancer-predisposing syndromePathogenic
(Mar 23, 2015)
criteria provided, single submitter
78.
GRCh37:
Chr16:2104322
GRCh38:
Chr16:2054321
TSC2L122fs, L133fs, L73fs, L85fsTuberous sclerosis 2Pathogenic
(Jun 11, 2020)
no assertion criteria provided
79.
GRCh37:
Chr16:2104360
GRCh38:
Chr16:2054359
TSC2E145*, E85*, E134*, E97*Tuberous sclerosis 2Pathogenic
(May 28, 2019)
criteria provided, single submitter
80.
GRCh37:
Chr16:2104372
GRCh38:
Chr16:2054371
TSC2E138*, E149*, E89*, E101*not providedPathogenic
(Aug 10, 2017)
criteria provided, single submitter
81.
GRCh37:
Chr16:2104381
GRCh38:
Chr16:2054380
TSC2E141*, E92*, E104*, E152*Tuberous sclerosis 2Pathogenic
(Jun 27, 2016)
criteria provided, single submitter
82.
GRCh37:
Chr16:2104385
GRCh38:
Chr16:2054384
TSC2F154fs, F143fs, F94fs, F106fsnot providedPathogenic
(Nov 25, 2016)
criteria provided, single submitter
83.
GRCh37:
Chr16:2104398-2104399
GRCh38:
Chr16:2054397-2054398
TSC2T110fs, T158fs, T147fs, T98fsTuberous sclerosis 2Pathogenic
(Jun 7, 2019)
criteria provided, single submitter
84.
GRCh37:
Chr16:2104400
GRCh38:
Chr16:2054399
TSC2T147K, T158K, T98K, T110KTuberous sclerosis 2Likely pathogenic
(Aug 12, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr16:2104432
GRCh38:
Chr16:2054431
TSC2E109*, R9S, E169*, E188*, E121*, E139*, E158*Tuberous sclerosis 2Pathogenic
(Sep 26, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr16:2104435
GRCh38:
Chr16:2054434
TSC2E159*, E170*, E110*, E122*Tuberous sclerosis 2Pathogenic
(Dec 15, 2017)
criteria provided, single submitter
87.
GRCh37:
Chr16:2104438
GRCh38:
Chr16:2054437
TSC2L160V, L171V, L111V, L123Vnot providedLikely pathogenic
(May 10, 2017)
criteria provided, single submitter
88.
GRCh37:
Chr16:2104442
GRCh38:
Chr16:2054441
TSC2Cortical tubers, Focal cortical dysplasia, Tuberous sclerosis 2
Pathogenic
(Jul 12, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr16:2104442
GRCh38:
Chr16:2054441
TSC2Tuberous sclerosis syndromePathogenic
(Jun 15, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr16:2104446
GRCh38:
Chr16:2054445
TSC2Tuberous sclerosis 2Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr16:2104446
GRCh38:
Chr16:2054445
TSC2not providedPathogenic
(Feb 1, 2017)
criteria provided, single submitter
92.
GRCh37:
Chr16:2105402
GRCh38:
Chr16:2055401
TSC2not providedPathogenic
(Aug 10, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr16:2105402
GRCh38:
Chr16:2055401
TSC2Tuberous sclerosis 2Likely pathogenic
(Jan 4, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr16:2105408-2105409
GRCh38:
Chr16:2055407-2055408
TSC2F114fs, F163fs, F126fs, F174fsnot provided, Tuberous sclerosis 2Pathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr16:2105417
GRCh38:
Chr16:2055416
TSC2Q166*, Q177*, Q117*, Q129*not provided, Tuberous sclerosis 2Pathogenic
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr16:2105420-2105427
GRCh38:
Chr16:2055419-2055426
TSC2W118fs, W178fs, W130fs, W167fsTuberous sclerosis 2Pathogenic
(Jul 23, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr16:2105421
GRCh38:
Chr16:2055420
TSC2W167*, W178*, W118*, W130*Tuberous sclerosis 2, not providedPathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr16:2105422
GRCh38:
Chr16:2055421
TSC2W130*, W178*, W118*, W167*LymphangiomyomatosisPathogenic
(Nov 14, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr16:2105427
GRCh38:
Chr16:2055426
TSC2D120fs, D169fs, D132fs, D180fsnot providedPathogenic
(Jul 3, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr16:2105434-2105435
GRCh38:
Chr16:2055433-2055434
TSC2L135fs, L123fs, L172fs, L183fsTuberous sclerosis 2Pathogenic
(Feb 22, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination